renal cell carcinoma

Patterns and Predictors of Oral Anticancer Agent Use for Metastatic RCC
Videos
Patterns and Predictors of Oral Anticancer Agent Use for Metastatic RCC
03/18/2021
03/18/2021
Journal of Clinical Pathways
Real-World Treatment Sequences After First-Line Therapy in Metastatic RCC
Videos
Real-World Treatment Sequences After First-Line Therapy in Metastatic RCC
03/18/2021
03/18/2021
Journal of Clinical Pathways
Research in Review
Removing Metastases Improves Survival for Patients With Kidney Cancer
04/28/2017
JCP Editors
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
Patients with renal cell carcinoma who have surgery to remove metastatic tumors are likely to double their life expectancy, according to research published in The Journal of Urology (April...
...
04/28/2017
Journal of Clinical Pathways
Department
Pazopanib More Cost-Effective Than Sunitinib for Patients With Renal Cell Carcinoma
04/12/2017
JCP Editors
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib (Votrient, Novartis) rather than sunitinib (Sutent, Pfizer). Advanced renal cell...
...
04/12/2017
Journal of Clinical Pathways
Research in Review
Pazopanib Cost-Effective for Patients With Renal Cell Carcinoma
03/28/2017
JCP Editors
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...
Medicare patients with advanced renal cell carcinoma benefit from lower costs and hospital admissions if treated with pazopanib rather than sunitinib, according to research presented at the AMCP Managed Care &...
...
03/28/2017
Journal of Clinical Pathways
Research in Review
Kidney Cancer Pulmonary Metastases May Hide Primary Lung Cancer Diagnosis
03/27/2017
JCP Editors
Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research. ----- Related Content Leptomeningeal Metastases More Common in EGFR+...
Primary non-small cell lung cancer (NSCLC) may be underdiagnosed in patients with metastatic renal cell carcinoma, according to new research. ----- Related Content Leptomeningeal Metastases More Common in EGFR+...
...
03/27/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
LLM Winter Symposium
February 7 ⁠–⁠ February 9
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
GD Solid Tumors
March 22 ⁠–⁠ March 23
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 4
WoundCon
May 1 ⁠–⁠ May 3
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use